Encellin

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$9.9M

Encellin is a biotech company developing an encapsulated cell therapy platform aimed at treating Type 1 Diabetes by enabling therapeutic cells to exchange biomolecules with the body, potentially offering a living medicine solution.